The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains. The European Directorate for the Quality of Medicines (EDQM) ...
SANDWICH, United Kingdom, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (BBC) has achieved a groundbreaking milestone by submitting one of the world’s first CEP (Certification of ...
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare Advancing Pharmaceutical Innovation ...
Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 ...
Advancing Pharmaceutical Innovation: Brains Bioceutical's CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals' CBD-Based Epilepsy Drug and 2024 $1.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results